Finance & investing
Investment decisions become fixated on easily quantifiable metrics like P/E ratios, quarterly earnings, or revenue growth rates while ignoring harder-to-measure factors like management quality, company culture, competitive moat, or long-term strategic positioning—leading to overvaluation of companies that look good on paper but are structurally fragile.
Medicine & diagnosis
Clinical trials and treatment decisions overweight easily measurable endpoints like progression-free survival or blood marker levels while underweighting patient quality of life, functional capacity, psychological wellbeing, and treatment burden—leading to therapies that extend measurable survival metrics without improving the patient's lived experience.